Clinical Trials Browser

Phase 2/3 × N-dihydrogalactochitosan × 90 days × Clear all

NCT07321847 2026-01-07

INJECTABL-3

Phase 2/3 Not yet recruiting

Gastrointestinal

Neoplasm Metastasis, Neoplasms, Rectal Neoplasms, Colorectal Neoplasms